4//SEC Filing
Brandt Kevin D 4
Accession 0001235802-21-000108
CIK 0001453593other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:32 PM ET
Size
9.3 KB
Accession
0001235802-21-000108
Insider Transaction Report
Form 4
Brandt Kevin D
VP & Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-08-15+199,519→ 199,519 totalExercise: $1.27Exp: 2031-08-15→ Common Stock (199,519 underlying) - Award
Common Stock, $0.000001 par value
2021-08-15+162,109→ 323,661 total - Tax Payment
Common Stock, $0.000001 par value
2021-08-15$1.20/sh−7,169$8,603→ 316,492 total
Footnotes (3)
- [F1]These shares will vest and be issued with respect to 40,527 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 40,528 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
- [F2]Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
- [F3]This option vests with respect to 49,879 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001692661
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:32 PM ET
- Size
- 9.3 KB